A Comparison of Plasmid DNA and mRNA as Vaccine Technologies

This review provides a comparison of the theoretical issues and experimental findings for plasmid DNA and mRNA vaccine technologies. While both have been under development since the 1990s, in recent years, significant excitement has turned to mRNA despite the licensure of several veterinary DNA vacc...

Full description

Bibliographic Details
Main Author: Margaret A. Liu
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/7/2/37
_version_ 1798005832276770816
author Margaret A. Liu
author_facet Margaret A. Liu
author_sort Margaret A. Liu
collection DOAJ
description This review provides a comparison of the theoretical issues and experimental findings for plasmid DNA and mRNA vaccine technologies. While both have been under development since the 1990s, in recent years, significant excitement has turned to mRNA despite the licensure of several veterinary DNA vaccines. Both have required efforts to increase their potency either via manipulating the plasmid DNA and the mRNA directly or through the addition of adjuvants or immunomodulators as well as delivery systems and formulations. The greater inherent inflammatory nature of the mRNA vaccines is discussed for both its potential immunological utility for vaccines and for the potential toxicity. The status of the clinical trials of mRNA vaccines is described along with a comparison to DNA vaccines, specifically the immunogenicity of both licensed veterinary DNA vaccines and select DNA vaccine candidates in human clinical trials.
first_indexed 2024-04-11T12:46:33Z
format Article
id doaj.art-7f70c8bf80cc4a01882db0944cf1d4a9
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-04-11T12:46:33Z
publishDate 2019-04-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-7f70c8bf80cc4a01882db0944cf1d4a92022-12-22T04:23:21ZengMDPI AGVaccines2076-393X2019-04-01723710.3390/vaccines7020037vaccines7020037A Comparison of Plasmid DNA and mRNA as Vaccine TechnologiesMargaret A. Liu0ProTherImmune, 3656 Happy Valley Road, Lafayette, CA 94549, USAThis review provides a comparison of the theoretical issues and experimental findings for plasmid DNA and mRNA vaccine technologies. While both have been under development since the 1990s, in recent years, significant excitement has turned to mRNA despite the licensure of several veterinary DNA vaccines. Both have required efforts to increase their potency either via manipulating the plasmid DNA and the mRNA directly or through the addition of adjuvants or immunomodulators as well as delivery systems and formulations. The greater inherent inflammatory nature of the mRNA vaccines is discussed for both its potential immunological utility for vaccines and for the potential toxicity. The status of the clinical trials of mRNA vaccines is described along with a comparison to DNA vaccines, specifically the immunogenicity of both licensed veterinary DNA vaccines and select DNA vaccine candidates in human clinical trials.https://www.mdpi.com/2076-393X/7/2/37DNA vaccinemRNA vaccineplasmid DNAin vitro transcribed mRNAimmune responsesformulationsCytolytic T Lymphocytesantibodiesinnate immunity
spellingShingle Margaret A. Liu
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
Vaccines
DNA vaccine
mRNA vaccine
plasmid DNA
in vitro transcribed mRNA
immune responses
formulations
Cytolytic T Lymphocytes
antibodies
innate immunity
title A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
title_full A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
title_fullStr A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
title_full_unstemmed A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
title_short A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
title_sort comparison of plasmid dna and mrna as vaccine technologies
topic DNA vaccine
mRNA vaccine
plasmid DNA
in vitro transcribed mRNA
immune responses
formulations
Cytolytic T Lymphocytes
antibodies
innate immunity
url https://www.mdpi.com/2076-393X/7/2/37
work_keys_str_mv AT margaretaliu acomparisonofplasmiddnaandmrnaasvaccinetechnologies
AT margaretaliu comparisonofplasmiddnaandmrnaasvaccinetechnologies